Nanoscale therapeutics for erectile dysfunction: a meta-analysis of stem cell-derived extracellular vesicles as natural nanoparticles in diabetic rat models

纳米级疗法治疗勃起功能障碍:干细胞衍生细胞外囊泡作为天然纳米颗粒在糖尿病大鼠模型中的荟萃分析

阅读:1

Abstract

BACKGROUND: Erectile dysfunction (ED), a prevalent male sexual disorder, severely impacts quality of life. Extracellular vesicles (EVs), natural nanoparticles (30-200 nm) secreted by stem cells, represent a novel nanomedicine platform for ED treatment due to their ability to encapsulate bioactive cargo (e.g., miRNAs, proteins) and target damaged tissues. Stem cell-derived extracellular vesicles (SC-EVs) have emerged as a promising therapeutic strategy for multiple diseases. This meta-analysis evaluates the therapeutic efficacy of SC-EVs in rat ED models and explores their translational potential. METHODS: We systematically searched PubMed, Embase, Cochrane Library, and Web of Science for studies published up to December 2024. Randomized controlled trials (RCTs) assessing EVs in ED treatment were included. A random-effects model was applied to account for between-study heterogeneity, with standardized mean differences (SMDs) and 95% confidence intervals (CIs) calculated for continuous outcomes. RESULTS: Twenty studies involving 324 rats were included. EVs significantly improved erectile function (SMD = 4.19, 95% CI: 3.31-5.08, P < 0.00001). Subgroup analyses revealed no significant differences between EV sources (e.g., mesenchymal stem cells [MSCs] vs. adipose-derived stem cells [ADSCs], P > 0.05) or disease models (diabetes mellitus [DM] vs. cavernous nerve injury [CNI], P > 0.05). EVs upregulated the expression of nitric oxide synthase isoforms (nNOS and eNOS), increased smooth muscle content (α-SMA), and improved smooth muscle-to-collagen ratios (P < 0.00001 for all). Funnel plot asymmetry and Egger's test (P < 0.05) indicated publication bias, but trim-and-fill analysis confirmed robust results post-adjustment. CONCLUSION: SC-EVs demonstrate significant therapeutic potential for ED in rat models, particularly in restoring vascular and neural integrity. However, limitations include small sample sizes and short follow-up periods. Future research should prioritize clinical translation, mechanistic exploration, and standardized EV production protocols.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。